Actavis Cautionary
Statement Regarding Forward-Looking Statements
3
Statements contained in this communication that refer to Actavis estimated or anticipated
future results, including estimated synergies, or other
non-historical facts are
forward-looking statements that reflect Actavis current perspective of existing trends and information as of the date of this
communication. Forward looking statements generally will be accompanied by words such as
anticipate, believe, plan, could, should,
estimate, expect, forecast, outlook,
guidance, intend, may, might, will, possible, potential, predict, project, or other similar words,
phrases or expressions. Such forward-looking statements include, but are not limited to,
statements about the benefits of the Forest acquisition,
including future financial and
operating results, Actavis or Forests plans, objectives, expectations and intentions and the expected timing of
completion of the transaction. It is important to note that Actavis goals and expectations are
not predictions of actual performance. Actual results
may differ materially from Actavis
current expectations depending upon a number of factors affecting Actavis business, Forests business and risks
associated with acquisition transactions. These factors include, among others, the inherent
uncertainty associated with financial projections;
restructuring in connection with, and
successful closing of, the Forest acquisition; subsequent integration of the Forest acquisition and the ability to
recognize the anticipated synergies and benefits of the Forest acquisition; the ability to obtain
required regulatory approvals for the transaction
(including the approval of antitrust
authorities necessary to complete the acquisition), the timing of obtaining such approvals and the risk that such
approvals may result in the imposition of conditions that could adversely affect the combined company
or the expected benefits of the transaction;
the ability to obtain the requisite Forest and
Actavis shareholder approvals; the risk that a condition to closing of the Forest acquisition may not be
satisfied on a timely basis or at all; the failure of the proposed transaction to close for any other
reason; risks relating to the value of the Actavis
shares to be issued in the transaction; the
anticipated size of the markets and continued demand for Actavis and Forests products; the impact of
competitive products and pricing; access to available financing (including financing for the
acquisition or refinancing of Actavis or Forest debt) on a
timely basis and on reasonable
terms; the risks of fluctuations in foreign currency exchange rates; the risks and uncertainties normally incident to
the pharmaceutical industry, including product liability claims and the availability of product
liability insurance on reasonable terms; the difficulty of
predicting the timing or outcome of
pending or future litigation or government investigations; periodic dependence on a small number of products for
a material source of net revenue or income; variability of trade buying patterns; changes in
generally accepted accounting principles; risks that the
carrying values of assets may be
negatively impacted by future events and circumstances; the timing and success of product launches; the difficulty
of predicting the timing or outcome of product development efforts and regulatory agency approvals or
actions, if any; market acceptance of and
continued demand for Actavis and Forests
products; costs and efforts to defend or enforce intellectual property rights; difficulties or delays in
manufacturing; the availability and pricing of third party sourced products and materials; successful
compliance with governmental regulations
applicable to Actavis and Forests
facilities, products and/or businesses; changes in the laws and regulations affecting, among other things, pricing
and reimbursement of pharmaceutical products; changes in tax laws or interpretations that could
increase Actavis consolidated tax liabilities; the
loss of key senior management or
scientific staff; and such other risks and uncertainties detailed in Actavis periodic public filings with the Securities
and Exchange Commission, including but not limited to Actavis Annual Report on form 10-K
for the year ended December 31, 2012 and from time
to time in Actavis other investor
communications. Except as expressly required by law, Actavis disclaims any intent or obligation to update or revise
these forward-looking statements.
|